Dr Liz Christie is a Group Leader in the Cancer Evolution and Metastasis Program at the Peter MacCallum Cancer Centre, Melbourne. Her laboratory seeks to understand how ovarian and endometrial cancers evolve to become resistant to treatment using genomics and bioinformatics and patient samples. Liz’s research program also seeks to develop ctDNA biomarkers of resistance, and the lab’s overall goal is to identify treatments that can overcome different resistance mechanisms.